#1 for women · Top pick
Grade ACoreAge Rx
The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
Luna Fit
93/100
Women's metabolic health · Independent · 2026
GLP-1 care that accounts for women's bodies.
PCOS, perimenopause, hormones and labs change what “a good provider” means. We review GLP-1 telehealth through a women's-health lens and rank each on the Luna Fit Score — 65 reviewed and scored on the evidence.
“A good provider for a woman with PCOS is not automatically a good provider for a woman in perimenopause.”
Hormonal suitability is scored as its own factor rather than folded into a single star rating — which is why the ranking here differs from a general GLP-1 list.
How the Luna Fit Score worksStart here
The women's-health angle, in three guides
PCOS01
PCOS & insulin resistance
Why GLP-1 medicines target the metabolic engine of PCOS — and what to ask a provider about tirzepatide, labs and androgens.
Read the guide →
Perimenopause02
Perimenopause & menopause
The midlife metabolic shift is real. How GLP-1 care fits alongside the hormonal changes of the menopause transition.
Read the guide →
Hormones03
Cycle & hormones
Appetite, thyroid, contraception and the menstrual cycle — the women's-specific questions worth raising before you start.
Read the guide →The ranking · 65 reviewed
Best GLP-1 providers for women
Scored on six women's-health factors: pcos & hormonal suitability · clinical oversight & labs · price transparency · nationwide access · ongoing support · cancellation fairness. Assume any provider we list may compensate us — see our disclosure. See the full write-up on our best GLP-1 for women hub, or — if PCOS is the reason you're here — the same providers ranked on our PCOS & hormonal suitability score.
1Best for women
Luna Fit
93/100
CoreAge Rx
The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Both compounded semaglutide and tirzepatide on one account — tirzepatide is often preferred where insulin resistance drives PCOS weight
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Available in all 50 states — no coverage gaps if you move or travel
- Not the rock-bottom price — budget shoppers can find cheaper teaser tiers elsewhere
- No FDA-approved brand-name option (compounded only)
- General metabolic program rather than a dedicated hormone/PCOS clinic
2Ranked
Luna Fit
92/100
Enhance MD
A tiered compounded program that lays every price on the table — semaglutide, tirzepatide, a microdose lane, and a combo option — with six-month metabolic lab testing and an NAD+ adjacency that speaks to women thinking about metabolism as a whole system.
- Semaglutide
- $212/mo
- Tirzepatide
- $280/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Unusually transparent tiered pricing — semaglutide $212/mo (first month $112), tirzepatide $280/mo, microdose $169/mo, and a combo option at $322/mo
- Dose-flat billing, so a titration up doesn't quietly raise your monthly cost
- Six-month metabolic lab testing with provider oversight — a real clinical loop, not a prescription-only handoff
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- No brand-name path and no oral or sublingual route for the needle-averse
- Licensed in all 50 states, though their own FAQ lists product as launched in 40 plus DC so far — worth confirming your state before you start
3Ranked
Luna Fit
86/100
yourEra
Both molecules at prices you can see up front, wrapped in a wider menu — NAD+, microdosing, and an optional coaching-and-labs bundle — for a woman who wants weight care and energy alongside it.
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
- Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
- Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted
- Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
- Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
- Injectable only — no oral route and no brand-name lane
4Ranked
Luna Fit
85/100
Sesame Care
An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
- Semaglutide
- From $149/mo (brand Wegovy pill)
- Tirzepatide
- Brand Zepbound (price varies)
- Coverage
- Nationwide marketplace
- Brand-name
- Yes
- Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
- Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
- You choose the provider and see the price up front — genuine marketplace transparency
- A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
- Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
- Brand-name cash prices can run high without insurance
5Ranked
Luna Fit
85/100
HealthRX
A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.
- Semaglutide
- $189/mo
- Tirzepatide
- $349/mo
- Coverage
- Not publicly listed
- Brand-name
- Yes
- LegitScript-certified (a meaningful third-party trust signal) with physician-supervised care, not a prescription-only handoff
- Both molecules plus a rare oral GLP-1 tablet — real optionality for the needle-averse and for insulin-resistant PCOS
- Transparent, no-insurance flat pricing — injectable GLP-1 around $189/mo, oral tablet around $239/mo, GLP+GIP around $349/mo
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- Some tiers are company-stated and the public site is thin, so a few figures can't be verified live
- Brand-name tiers are pass-through and expensive — brand Ozempic runs about $1,299/mo
60 more, ranked the same way
Ranks 6–65 score lower on the same six factors, not on a different rubric. Every one has a full scorecard.
Pricing, states and verification facts reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on the provider's site. Not medical advice.
Before you start
Is GLP-1 care worth a conversation?
A quick, private self-check framed for women's metabolic health. Nothing is saved or sent — it simply helps you decide whether to raise GLP-1 care with a clinician.
A gentle self-check
Is GLP-1 care worth a conversation for you?
Reflective only — not a diagnosis. Nothing is saved or sent.
0 of 6 selected. Tick the ones that sound like you — there are no wrong answers.
A women's-health rubric
Six factors weighted for women — PCOS and hormonal suitability, labs and oversight — applied the same way to every provider we review.
Honest about limits
Most telehealth brands aren't hormone clinics. We say where the PCOS or perimenopause framing is general, and rank accordingly.
Funded openly
Assume any provider we list may compensate us — we may earn a commission if you start care through some of these links, at no extra cost to you. Full detail in our disclosure.